1. Home
  2. XENE vs BANC Comparison

XENE vs BANC Comparison

Compare XENE & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • BANC
  • Stock Information
  • Founded
  • XENE 1996
  • BANC 1941
  • Country
  • XENE Canada
  • BANC United States
  • Employees
  • XENE N/A
  • BANC N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • BANC Major Banks
  • Sector
  • XENE Health Care
  • BANC Finance
  • Exchange
  • XENE Nasdaq
  • BANC Nasdaq
  • Market Cap
  • XENE 2.4B
  • BANC 2.3B
  • IPO Year
  • XENE 2014
  • BANC N/A
  • Fundamental
  • Price
  • XENE $35.99
  • BANC $15.16
  • Analyst Decision
  • XENE Strong Buy
  • BANC Buy
  • Analyst Count
  • XENE 10
  • BANC 11
  • Target Price
  • XENE $53.20
  • BANC $17.18
  • AVG Volume (30 Days)
  • XENE 932.8K
  • BANC 2.6M
  • Earning Date
  • XENE 08-11-2025
  • BANC 07-23-2025
  • Dividend Yield
  • XENE N/A
  • BANC 2.76%
  • EPS Growth
  • XENE N/A
  • BANC N/A
  • EPS
  • XENE N/A
  • BANC 0.65
  • Revenue
  • XENE $7,500,000.00
  • BANC $949,659,000.00
  • Revenue This Year
  • XENE N/A
  • BANC $8.71
  • Revenue Next Year
  • XENE $253.71
  • BANC $12.84
  • P/E Ratio
  • XENE N/A
  • BANC $22.33
  • Revenue Growth
  • XENE N/A
  • BANC 150.32
  • 52 Week Low
  • XENE $26.74
  • BANC $11.52
  • 52 Week High
  • XENE $46.00
  • BANC $18.08
  • Technical
  • Relative Strength Index (RSI)
  • XENE 69.83
  • BANC 59.29
  • Support Level
  • XENE $32.78
  • BANC $14.31
  • Resistance Level
  • XENE $34.63
  • BANC $14.64
  • Average True Range (ATR)
  • XENE 1.48
  • BANC 0.37
  • MACD
  • XENE 0.45
  • BANC -0.02
  • Stochastic Oscillator
  • XENE 79.01
  • BANC 88.89

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

Share on Social Networks: